Rechercher ( 9915 résultats )
- article
(Mis à jour le )
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a...
- article
(Mis à jour le )
Age at death during the Covid-19 lockdown in French metropolitan regions: a non parametric quantile regression approach
Background: Lockdowns have been implemented to limit the number of hospitalisations and deaths during the first wave of 2019 coronavirus disease. These measures may have affected...
- article
(Mis à jour le )
Activités et profils des patients affectés par l’épidémie de Covid-19 au centre hospitalier universitaire de Bordeaux
Contexte – Les baisses de recours aux soins hospitaliers constatées en début de 1re vague de Covid-19 peuvent être lourdes de conséquences et préjudiciables pour la santé des patients....
- article
(Mis à jour le )
Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study
BACKGROUND: Given the widespread implementation of COVID-19 vaccination to mitigate the pandemic from the end of 2020, it is important to retrospectively evaluate its impact, in...
- article
(Mis à jour le )
A comparison of COVID-19 incidence rates across six European countries in 2021
International comparisons of COVID-19 incidence rates have helped gain insights into the characteristics of the disease, benchmark disease impact, shape public health measures and...
- article
(Mis à jour le )
Monitoring the reproductive number of COVID-19 in France: Comparative estimates from three datasets
BACKGROUND: The effective reproduction number (Rt) quantifies the average number of secondary cases caused by one person with an infectious disease. Near-real-time monitoring of Rt...
- article
(Mis à jour le )
L’épidémiologie de la tuberculose en France à l’ère de la pandémie de Covid-19
Introduction – La France est un pays de faible incidence de tuberculose, avec une baisse moyenne de près de 5% par an depuis un demi-siècle. Cette tendance régulière a néanmoins été...
- article
(Mis à jour le )
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022
BACKGROUND: The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in early 2020 and subsequent implementation of public health and social measures (PHSM)...
- article
(Mis à jour le )
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France
The emergence of SARS-CoV-2 variants calls for continuous monitoring of vaccine effectiveness (VE). We estimated the absolute effectiveness of complete 2-dose primary vaccination and...
- article
(Mis à jour le )
Impact d'un rappel automatique de dépistage du VIH dans un logiciel de suivi de patientèle de médecine générale en période de Covid-19
En 2017, la Haute Autorité de santé (HAS) a réévalué sa stratégie de dépistage du virus de l'immunodéficience humaine (VIH), et en 2018, le Programme commun des Nations unies sur le...
